Antimycobacterial activity of some medicinal plants in Niger state, Nigeria by Mann, A et al.
Mann et al.,  Afr. J. Infect. Dis. (2009) 3(2): 44 -48 44
Research Paper
ISSN: 2006-0165©2009
ANTIMYCOBACTERIAL ACTIVITY OF SOME MEDICINAL PLANTS IN NIGER STATE, 
NIGERIA
Abdullahi Mann1,*, Kolo Ibrahim2, Adebayo O. Oyewale3, Joseph O. Amupitan3 and Joseph I.
Okogun4
1Department of Science Laboratory Technology, The Federal Polytechnic, Bida, P. M. B. 55, Bida, Niger 
State, Nigeria, 2Department of Microbiology and Biotechnology, National Institute for Pharmaceutical 
Research and Development (NIPRD), P. M. B. 21, Garki – Abuja, Nigeria
3Department of Chemistry, Ahmadu Bello University Zaria, Kaduna State, Nigeria
4Department of Medicinal Plant Research and Traditional Medicine, National Institute for Pharmaceutical 
Research and Development (NIPRD), P. M. B. 21, Garki – Abuja, Nigeria
*E-mail: abdumann@yahoo.com , Tel: +2348036368173
"Kolo Doko" kolodoko@yahoo.com, "Prof Adebayo O Oyewale" oyewaleao@yahoo.co.uk, "Prof 
Amupitan" amupitan@yahoo.com, "Joseph Okogun" jokogun@yahoo.com
Abstract
Ten Nigerian medicinal plants Abrus precatorius, Annona senegalensis, Anogeissus leiocarpus, Crateva 
adansonii, Detarium microcarpum, Faba spp, Neocarya macrophylla, Ocimum gratissimum, Securidaca
longpenduculata and Terminalia avicennioides used by traditional medicine practitioners for the management of 
infectious and chronic diseases such as tuberculosis and whooping cough were investigated for in vitro 
antimycobacterial activity against attenuated strains of Mycobacterium bovis (BCG). Hexane and methanol extracts 
of the plant materials were obtained by maceration. The antimycobacterial activity was determined by the broth 
microdilution method. The hexane extracts of Anogeissus leiocarpus and Terminalia avicennioides showed strong 
inhibitory activity at 312µg/ml. Eight of the ten plant extracts showed moderate inhibitory activity in either hexane 
or methanol extract at 1250µg/ml. While the hexane and methanol extracts of Detarium microcarpum and Neocarya 
macrophylla did not exhibit any significant activity. These observed activities could be associated with secondary 
metabolites in these plants. This study demonstrates the efficacy of Nigerian medicinal plants as potential agents in 
the management of the tuberculosis disease. 
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Introduction
Since the beginning of human civilization plants have been used to treat common infectious diseases. Some of 
these traditional medicines are still very much in use as part of the health care delivery in Nigeria. Although 
antimicrobial drugs have saved many lives and eased the suffering of millions, multi-resistant syndrome has 
tremendously limited the benefits of some of these drugs in controlling infectious diseases. Indigenous plants are 
reservoirs of various metabolites which provide a limitless source of important chemicals that have diverse biological 
properties. Tuberculosis (TB) persists as a leading global cause of death (WHO, 2005). The World Health 
Organization declared tuberculosis as an emergency, which requires global action especially searching for new
remedies or agents to complement current ones. The emergence of multi-drugs resistant strains of M. tuberculosis as 
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well as its opportunistic infection with Human Immunodeficiency Virus, have significantly led to increased pressure 
on the current chemotherapy. This scenario calls for the continuous search for the discovery of new, effective, and 
affordable anti-tuberculosis agents to deal with the present situation.
Globally, plants are used as the main constituents in the traditionally treatment of tuberculosis and related 
diseases (Mann, 2007). Several Nigerian plant extracts have been known with microbial activities (Adeleye et al.,
2008; Ibrahim et al., 2005; Malcolm and Sofowora, 1969; Mann et al., 2007; 2008a, b, c). Furthermore, the potential 
of higher plant extracts as sources of novel anti-TB leads (Mitscher and Baker, 1998) have also been known. Bacillus 
Calmette Guerin (BCG), attenuated strains of Mycobacterium bovis has been used as a surrogate test organism for 
screening for antitubercular activity (Mann et al., 2008c). This study is to evaluate some Nigerian medicinal plants 




Plants were selected based on the ethnobotanical uses to treat tuberculosis or related symptoms. The plant 
parts used were obtained as described by traditional medical practitioners from a forest near Emitete, Niger State, 
Nigeria. Voucher specimens were deposited in the Herbarium at the Department of Biological Sciences, Ahmadu 
Bello University (ABU), Zaria, Nigeria and National Institute for Pharmaceutical Research and Development 
(NIPRD), Abuja, Nigeria with the Herbarium numbers indicated. Approximately 1kg of fresh plant material of each 
species was collected and air-dried.
Extraction and fractionation 
Two hundred grams (200g) of each dried plant material was powdered and extracted by maceration with 70% 
methanol for 72h at room temperature (3 x 250mL). All the crude extracts were filtered and evaporated in vacuo
(350C). The crude methanol extract of each plant was then partitioned with n-hexane-MeOH (3 x 250mL, 1: 1) to 
give n -hexane and MeOH solubles. All the partitioned extracts for each plant concentrated and dried in vacuo. 
Stock solutions were prepared in dimethyl sulphoxide (DMSO) at a concentration of 20mg/mL and stored at -200C 
until use. The soluble fractions hexane and methanol of each plant species were tested for antimycobacterial activity 
using M. bovis (BCG).
Phytochemical analysis
The plant extracts were phytochemically screened to detect the presence of secondary metabolites such as 
carbohydrates, saponins, tannins, terpenoids, anthraquinones, steroids and alkaloids in accordance with standard 
methods (Brain and Turner 1975; Harborne, 1975; Trease and Evans, 1989).   
Mycobacterium species
The extracts were screened for antimycobacterial activity against a clinical isolate of Mycobacterium 
tuberculosis and a strain of Mycobacterium bovis (BCG) using a broth microdilution method. The bacterial culture of 
Mycobacterium tuberculosis clinical isolates was obtained from the Diagnostic Laboratory of National Institute for 
Pharmaceutical Research and Development (NIPRD), Garki – Abuja, Nigeria and the activity evaluation against M. 
tuberculosis was done at the TB Research Section, Zankli Medical Laboratory, Garki-Abuja, Nigeria. BCG was 
obtained from the National Institute of Allergy and Infectious Diseases (NIAID), TB Research Section, NIH, 
Maryland, USA and cultured at the Department of Microbiology and Biotechnology, NIPRD, Abuja, Nigeria. 
Inocula preparation 
The inocula preparation of the clinical isolates of Mycobacterium tuberculosis and BCG were grown on 
Lowenstein Jensen medium (LJ) and subcultured in Middlebrook 7H9 broth supplemented with Albumin Dextrose 
Complex (ADC) at 37oC for 7days to yield activity grown cells of M. tuberculosis and BCG. The activity grown M. 
tuberculosis and BCG cultures had its optical density adjusted to between 0.2 - 0.3 at a wavelength of 650 nm using 
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Beckman counter DU520 UV-Visible spectrophotometer. The cultures were diluted at 1/1000 by adding 25μL cell 
culture to 25 mL Middlebrook 7H9 broth
Determination of antimycobacterial activity
Antimycobacterial activity susceptibility testing was conducted using the broth microdilution method (BMM) 
in 96 well microtitre plates as earlier reported by Mann et al. (2008).  The same procedure was repeated for the 
control, Rifampicin with an initial concentration of 32μg/mL and subsequent dilution to the final testing 
concentrations of 1, 0.5, 0.25, 0.125, 0.06, 0.03μg/mL. Appropriate solvent, growth and sterile controls were carried 
out with Rifampicin as positive control.  All plates were incubated initially at 370C for 7 days. The plates were re-
incubated at 370C for further 2 weeks. After this incubation, any well that turned cloudy was recorded as positive for 
growth. The minimum inhibitory concentration (MIC) was taken as the lowest extract concentration at which no 
mycobacterial growth was observed.
Results and Discussion
Selection of medicinal plants for the study
Plants were selected based on the performance index (Ip>0) of plants used to treat TB or related symptoms as 
reported in the survey by Mann et al. (2007). Performance index is an analytical tool for assessing the effectiveness 
of medicinal plants (Betti, 2004). The value of performance index obtained for a particular medicinal plant is 
indicative of its usefulness and the correctness of the information is often checked from the frequency of use by 
different healers across the region and also from the medicinal uses reported in literature. 
Phytochemical analysis of the extracts
The results of the phytochemical analysis (Table 1) indicate the presence of saponins in all the plants extracts
screened, while steroids, tannins, terpenes, and anthraquinones were observed in most of the plants tested.
Table 1: Phytochemical screening results of the crude methanolic extracts
Plant species A An Cb S St T Tp
Abrus precatorius + + + + + + +
Annona senegalensis + + - + + + +
Anogeissus leiocarpus - + + + - + +
Crateva adansonii + + + + - + +
Detarium microcarpium + + + + - + -
Faba spp + + + + + - +
Neocarya macrophylla + - + + + + -
Ocimum gratissimum + + - + + + +
Securidaca longpenduculata + + + + + + +
Terminalia avicennioides - + - + - + +
                     Key: (+) present,   (-) - absent, A-Alkaloids, An- Anthraquinone, Cb- Carbohydrate, S-Saponin,, 
St-Steroids, T-Tannin, Tp-Terpenoids
Extractive values and antimycobacterial activity of the extracts
The crude methanolic extracts from the ten plants were separately partitioned with n-hexane-methanol mixture 
to give the extractive values in Table 2. The extractive values of the ten selected plant species for the hexane soluble 
fractions ranged from (0.99-43.6%), while those of methanol soluble fractions ranged from (56.4- 99.01%). The 
details are shown in Table 2. 
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Table 2: The plant extracts and their corresponding percentage yields and antimycobacterial activity against BCG
Plants Species /Herbarium numbera Extract Amount (g) % Recovery MIC 
(g/ml)
Abrus precatorius 932 Hex   3.2 21.33 1250
MeOH 11.8 18.67 NA
Annona senegalensis  (5737) Hex   6.3 28.3 NA
MeOH 15.9 71.7 1250
Anogeissus leiocarpus  167 Hex   0.40   3.8 312
MeOH 10.00 96.2 1250
Crateva adansonii  6967 Hex   4.6 31.0 NA
MeOH 10.21 69.0 1250
Detarium microcarpium 900676 Hex   0.5   3.4 NA
MeOH 14.2 96.6 NA
Faba spp  * Hex   8.2 43.6 1250
MeOH 10.6 56.4 NA
Neocarya macrophylla  (5740) Hex   0.24   1.6 NA
MeOH 14.6 98.4 NA
Ocimum gratissimum   1285 Hex   7.1 24.1 1250
MeOH 22.3 75.9 NA
Securidaca longpenduculata (5742) Hex   4.4 25.9 NA
MeOH 12.6 74.1 1250
Terminalia avicennioides   (5735) Hex   0.20   0.99 312
MeOH 20.00 99.01 1250
Rifampicin 0.03
Key: Hex-Hexane, MeOH-Methanol, NA-Not Active; aHerbarium numbers of ABU are Unbracketed, while those of 
NIPRD are bracketed, *Number not assigned
Eight plants of ten exhibited some degree of antimycobacterial activity. Detarium microcarpium and 
Neocarya macrophylla did not exhibit any significant activity for both hexane and methanol extracts. Six plants’ 
extracts showed moderate inhibitory activity either in hexane or methanol fractions. Only the hexane fraction of 
extracts of A. leiocarpus and T. avicennioides showed activity at 312 g/mL (Table 2) against BCG. The present 
results are in conformity with those of Mann et al. (2008c) where the n-hexane extracts of A. leiocarpus and T. 
avicennioides showed the most significant inhibitory activity at 312.5 and 200 μg/mL respectively against BCG. This 
study also shows the antimycobacterial potential of these two plants in comparison to the other medicinal plants of 
Niger state, Nigeria.  This fraction deserves special attention in the exploration of chemotypes with anti-TB activity. 
It is pertinent to observe that hexane fractions of some plants contain essential oils which are biocidal against a broad 
range of organisms such as bacteria, fungi, protozoa, insects, plants, and viruses (Rosa et al., 2003). In particular it 
possesses the greatest use in the treatment of infectious pathologies in the respiratory system, urinary tract, 
gastrointestinal, and biliary systems, as well as on the skin. Various essential oils produce pharmacological effects, 
demonstrating anti-inflammatory, antioxidant, and anticarcinogenic properties (Lopes et al., 2000). It is generally 
recognized that the antimicrobial action of essential oils depends on their hydrophilic or lipophilic character. 
Terpenoids may serve as an example of lipid-soluble agents that affect the activities of membrane-catalyzed 
enzymes, for example their action on respiratory pathways. The mode of action of antimicrobial agents depends on 
the type of microorganism under consideration and is mainly related to their cell wall structure and the outer 
membrane arrangement. It has been proved that the effectiveness of the antibacterial agent generally increases with 
its lipophilic properties as a result of the action on cytomembranes. The hexane fractions of the two plants having the 
most active fractions contain terpenoids and saponins, which may be responsible for the associated activity (Table 2).
Among the plants found to possess inhibitory activity, a few were also reported to be active (Uba et al., 2003). The 
review of antimycobacterial natural products showed that metabolites such as terpenes, monoterpeniods, diterpenes, 
sesquiterpenes and triterpenes, steroids and alkaloids were found to possess antimycobacterial activity (Copp, 2003).
These metabolites were found to be abundant in the extracts of these plants studied. Therefore, they were reported to 
possess potential structural skeletons that could provide useful scaffolds / templates for the development of new 
antimycobacterial drugs. In Abrus precatorius, the active compounds associated with these activities have been 
isolated from the aerial parts of this plant as abruquinone B and abruquinone G, particularly abruquinone B exhibited 
antitubercular, antiplasmodial and cytotoxic activities (Limmatvapirat et al., 2004).  Katerere and co-workers isolated 
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imberbic acid with potent activity against Mycobacterium fortuitum and S. aureus from the stem bark of Terminalia 
spp. (Katerere et al., 2003). This observation makes these plants with good activity interesting for further 
investigation. 
Conclusion
This study illustrates that the hexane extracts of Nigerian medicinal plants could be good sources of 
metabolites with antimycobacterial activities worthy of further investigation. 
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